BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

(2011) Heather Thorne et al.   Cancer Prevention Research

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

(2010) S M Edwards et al.   BRITISH JOURNAL OF CANCER

Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer

(2010) D. J. Gallagher et al.   CLINICAL CANCER RESEARCH

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid progression of prostate cancer in men with a BRCA2 mutation

(2008) S A Narod et al.   BRITISH JOURNAL OF CANCER

Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation

(2008) A. J. Willems et al.   CLINICAL CANCER RESEARCH